{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:40:52Z","timestamp":1780461652118,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coviro.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T14:19:05Z","timestamp":1511446745000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Consequences of perinatal infections with rubella, measles, and mumps"],"prefix":"10.1016","volume":"27","author":[{"given":"Erika R","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2017.11.009_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-1157(76)90033-0","article-title":"Vaccination of infants in their first year of life with split inactivated measles vaccine incorporated in a diphtheriapertussis-tetanus-polio (inactivated) vaccine (DPTP-M), compared with live measles vaccination","volume":"4","author":"Brouwer","year":"1976","journal-title":"J Biol Stand"},{"key":"10.1016\/j.coviro.2017.11.009_bib0010","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.15585\/mmwr.mm6437a5","article-title":"Global progress toward rubella and congenital rubella syndrome control and elimination \u2013 2000\u20132014","volume":"64","author":"Grant","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2017.11.009_bib0015","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/pd.4467","article-title":"Rubella and pregnancy: diagnosis, management and outcomes","volume":"34","author":"Bouthry","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1099\/jgv.0.000680","article-title":"Genetic diversity of currently circulating rubella viruses: a need to define more precise viral groups","volume":"98","author":"Rivailler","year":"2017","journal-title":"J Gen Virol"},{"issue":"Pt 10","key":"10.1016\/j.coviro.2017.11.009_bib0025","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1099\/0022-1317-77-10-2523","article-title":"Nucleotide sequence analysis of a major antigenic domain of the E1 glycoprotein of 22 rubella virus isolates","volume":"77","author":"Bosma","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmi.2017.06.030","article-title":"Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase","volume":"23","author":"Santibanez","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coviro.2017.11.009_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/GRF.0b013e31824df256","article-title":"Measles, mumps, and rubella","volume":"55","author":"White","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0040","series-title":"Epidemiology and Prevention of Vaccine Preventable Diseases","article-title":"Rubella","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.coviro.2017.11.009_bib0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00313027409068988","article-title":"The pathology of congenital rubella: a review written by request","volume":"6","author":"Menser","year":"1974","journal-title":"Pathology"},{"key":"10.1016\/j.coviro.2017.11.009_bib0050","series-title":"Rubella virus","author":"Chantler","year":"2001"},{"issue":"Suppl 3","key":"10.1016\/j.coviro.2017.11.009_bib0055","first-page":"11","article-title":"Maternal rubella and its virological diagnosis","volume":"48","author":"Banatvala","year":"1972","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.coviro.2017.11.009_bib0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.1.5908.635","article-title":"Letter: diagnosis of rubella","volume":"1","author":"Banatvala","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.coviro.2017.11.009_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-0528.1985.tb01080.x","article-title":"Rubella\u2014continuing problems","volume":"92","author":"Banatvala","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.13.4.571","article-title":"Rubella virus replication and links to teratogenicity","volume":"13","author":"Lee","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2017.11.009_bib0075","series-title":"Rubella Fact Sheet","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.coviro.2017.11.009_bib0080","first-page":"279","article-title":"Achievements in public health: elimination of rubella and congenital rubella syndrome in the United States, 1969\u20132004","volume":"vol. 54","author":"Centers for Disease Control and Prevention","year":"2005"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0085","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/risa.12264","article-title":"Characterization of the risks of adverse outcomes following rubella infection in pregnancy","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal"},{"key":"10.1016\/j.coviro.2017.11.009_bib0090","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bmj.288.6423.1043","article-title":"Persistence of rubella antibody 8-18 years after vaccination","volume":"288","author":"O'Shea","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.coviro.2017.11.009_bib0095","doi-asserted-by":"crossref","first-page":"e73014","DOI":"10.1371\/journal.pone.0073014","article-title":"Persistent infection of human fetal endothelial cells with rubella virus","volume":"8","author":"Perelygina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2017.11.009_bib0100","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1128\/JVI.01152-05","article-title":"Analyses of phosphorylation events in the rubella virus capsid protein: role in early replication events","volume":"80","author":"Law","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0105","doi-asserted-by":"crossref","first-page":"e1001291","DOI":"10.1371\/journal.ppat.1001291","article-title":"The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of Bax","volume":"7","author":"Ilkow","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2017.11.009_bib0110","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1128\/JVI.02732-07","article-title":"Rubella virus capsid protein interacts with poly(a)-binding protein and inhibits translation","volume":"82","author":"Ilkow","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.01348-09","article-title":"The rubella virus capsid protein inhibits mitochondrial import","volume":"84","author":"Ilkow","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0120","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/cmi.12272","article-title":"Phosphorylation and membrane association of the Rubella virus capsid protein is important for its anti-apoptotic function","volume":"16","author":"Willows","year":"2014","journal-title":"Cell Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.coviro.2017.11.009_bib0125","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1093\/infdis\/jir118","article-title":"Global distribution of measles genotypes and measles molecular epidemiology","volume":"204","author":"Rota","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2017.11.009_bib0130","first-page":"249","article-title":"Nomenclature for describing the genetic characteristics of wild-type measles viruses (update)","volume":"76","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2017.11.009_bib0135","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jmv.20648","article-title":"Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic","volume":"78","author":"Gouandjika-Vasilache","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0140","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3201\/eid1611.100777","article-title":"Measles virus strain diversity, Nigeria and Democratic Republic of the Congo","volume":"16","author":"Kremer","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2017.11.009_bib0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7196\/SAMJ.2016.v106i7.10651","article-title":"Measles outbreak reveals measles susceptibility among adults in Namibia, 2009\u20132011","volume":"106","author":"Ogbuanu","year":"2016","journal-title":"S Afr Med J"},{"key":"10.1016\/j.coviro.2017.11.009_bib0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.11604\/pamj.2015.21.30.6335","article-title":"Antecedent causes of a measles resurgence in the Democratic Republic of the Congo","volume":"21","author":"Scobie","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.coviro.2017.11.009_bib0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jmv.20491","article-title":"Measles virus genotype B2 is not inactive: evidence of continued circulation in Africa","volume":"77","author":"Smit","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0160","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1016\/j.vaccine.2017.09.080","article-title":"County-level assessment of United States kindergarten vaccination rates for measles mumps rubella (MMR) for the 2014\u20132015 school year","volume":"35","author":"Kluberg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.11.009_bib0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2017.9984","article-title":"Incidence of measles in the United States, 2001\u20132015","volume":"318","author":"Clemmons","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2017.11.009_bib0170","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.42.17-00673","article-title":"Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017","volume":"22","author":"Currie","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2017.11.009_bib0175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00209-17","article-title":"Antigenic drift defines a new D4 subgenotype of measles virus","volume":"91","author":"Mu\u00f1oz-Al\u00eda","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0180","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.13.30177","article-title":"A unique measles B3 cluster in the United Kingdom and the Netherlands linked to air travel and transit at a large international airport, February to April 2014","volume":"21","author":"Nic Lochlainn","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2017.11.009_bib0185","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.17.19852-en","article-title":"Appearance of a novel measles G3 strain in multiple European countries within a two month period, 2010","volume":"16","author":"Brown","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2017.11.009_bib0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapediatrics.2016.1787","article-title":"Measles and measles vaccination: a review","volume":"170","author":"Bester","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.coviro.2017.11.009_bib0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.spen.2012.02.003","article-title":"Measles virus and associated central nervous system sequelae","volume":"19","author":"Buchanan","year":"2012","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0200","series-title":"Epidemiology and Prevention of Vaccine Preventable Diseases","article-title":"Measles","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.coviro.2017.11.009_bib0205","doi-asserted-by":"crossref","DOI":"10.3390\/v8100282","article-title":"The immune response in measles: virus control, clearance and protective immunity","volume":"8","author":"Griffin","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2017.11.009_bib0210","doi-asserted-by":"crossref","first-page":"14989","DOI":"10.1073\/pnas.1211138109","article-title":"Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics","volume":"109","author":"Lin","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2017.11.009_bib0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/hcu113","article-title":"Measles-induced encephalitis","volume":"108","author":"Fisher","year":"2015","journal-title":"QJM"},{"key":"10.1016\/j.coviro.2017.11.009_bib0220","first-page":"267","article-title":"SSPE-like inclusion body disorder in treated childhood leukemia","volume":"Suppl 6","author":"Sluga","year":"1975","journal-title":"Acta Neuropathol Suppl"},{"key":"10.1016\/j.coviro.2017.11.009_bib0225","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jcp.29.10.865","article-title":"Measles inclusion-body encephalitis in a child with treated acute lymphoblastic leukaemia","volume":"29","author":"Drysdale","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-510X(90)90244-H","article-title":"Notes on the pathogenesis of subacute sclerosing panencephalitis","volume":"95","author":"Poser","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coviro.2017.11.009_bib0235","first-page":"348","article-title":"Delayed acute measles inclusion body encephalitis in a 9-year-old girl: ultrastructural, immunohistochemical, and in situ hybridization studies","volume":"5","author":"Kim","year":"1992","journal-title":"Mod Pathol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0240","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1172\/JCI118306","article-title":"Brain endothelial cell infection in children with acute fatal measles","volume":"96","author":"Esolen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2017.11.009_bib0245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000150544","article-title":"Measles virus infections of the central nervous system","volume":"40","author":"Liebert","year":"1997","journal-title":"Intervirology"},{"key":"10.1016\/j.coviro.2017.11.009_bib0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.1819","article-title":"Genomic diversity of mumps virus and global distribution of the 12 genotypes","volume":"25","author":"Jin","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0255","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/13550280701658382","article-title":"A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo","volume":"13","author":"Malik","year":"2007","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0260","series-title":"Epidemiology and Prevention of Vaccine Preventable Diseases","article-title":"Mumps","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.coviro.2017.11.009_bib0265","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/JCM.00434-10","article-title":"Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland","volume":"48","author":"Carr","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2017.11.009_bib0270","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2017.11.009_bib0275","series-title":"Chapter 9: Mumps","author":"Fiebelkorn","year":"2012"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0280","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/21645515.2017.1330733","article-title":"The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study","volume":"13","author":"La Torre","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2017.11.009_bib0285","first-page":"226","article-title":"Three cases of congenital rubella syndrome in the postelimination era\u2014Maryland, Alabama, and Illinois, 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0290","doi-asserted-by":"crossref","first-page":"731","DOI":"10.15585\/mmwr.mm6529a2","article-title":"Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine \u2013 Illinois, 2015\u20132016","volume":"65","author":"Albertson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2017.11.009_bib0295","series-title":"Vaccine Preventable Diseases Monitoring System 2017 Global Summary","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.coviro.2017.11.009_bib0300","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4161\/hv.28389","article-title":"Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009\u20132010","volume":"10","author":"Kutty","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2017.11.009_bib0305","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00038-016-0842-8","article-title":"Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review","volume":"61","author":"Damm","year":"2016","journal-title":"Int J Public Health"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0310","article-title":"Progress and challenges in measles and rubella elimination in the WHO European Region","author":"Datta","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.11.009_sbref0315","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/1471-2458-13-406","article-title":"Health economics of rubella: a systematic review to assess the value of rubella vaccination","volume":"13","author":"Babigumira","year":"2013","journal-title":"BMC Public Health"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717301608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717301608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T01:37:12Z","timestamp":1659922632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625717301608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":63,"alternative-id":["S1879625717301608"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2017.11.009","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of perinatal infections with rubella, measles, and mumps","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}